Vidit Pharma Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 17 Days
- Last Filing with ROC 31 Mar 2023
About Vidit Pharma Sciences
Vidit Pharma Sciences Private Limited (VPSPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 January 2022 (Three years 17 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jayant Ranade and Shraddha Dhamankar serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U73200MH2022PTC375308
-
Company No.
375308
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Jan 2022
-
Date of AGM
15 Jul 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Vidit Pharma Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayant Ranade
|
Director | 21-Jan-2022 | Current |
|
Shraddha Dhamankar
|
Director | 21-Jan-2022 | Current |
Financial Performance of Vidit Pharma Sciences.
Vidit Pharma Sciences Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vidit Pharma Sciences?
In 2023, Vidit Pharma Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Thurs Organics Private LimitedShraddha Dhamankar is a mutual person
-
Nexgen Healthcare Private LimitedShraddha Dhamankar is a mutual person
-
Chemolutions Chemicals LimitedJayant Ranade is a mutual person
-
Enem Nostrum Remedies Private LimitedShraddha Dhamankar is a mutual person
-
Nli Healthcare (India) Private Limited
Shraddha Dhamankar is a mutual person
-
Excella Pencils Private LimitedJayant Ranade is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vidit Pharma Sciences?
Vidit Pharma Sciences has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vidit Pharma Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vidit Pharma Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.